Similar articles

• Letter: Isoniazid and the liver.

  Greenberg HB. Greenberg HB. Am Rev Respir Dis. 1975 May;111(5):708-9. doi: 10.1164/arrd.1975.111.5.708a. Am Rev Respir Dis. 1975. PMID: 1130761 No abstract available.
• Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children.

  Palusci VJ, O'Hare D, Lawrence RM. Palusci VJ, et al. Pediatr Infect Dis J. 1995 Feb;14(2):144-8. doi: 10.1097/00006454-199502000-00012. Pediatr Infect Dis J. 1995. PMID: 7746698 Review. No abstract available.
• [Increase in transaminases and jaundice during treatment with rifampicin combined with isoniazid].

  Kreis B, Boutonnet G. Kreis B, et al. Rev Tuberc Pneumol (Paris). 1970 Dec;34(8):1097-106. Rev Tuberc Pneumol (Paris). 1970. PMID: 5517156 French. No abstract available.
• [Detection of the effects of the rifampin-isoniazid combination on the human liver].

  Plomteux G, Heusghem C, Ferdinande R, Lecoq A, Winandy A, Parmentier JC. Plomteux G, et al. Nouv Presse Med. 1974 Mar 23;3(12):727-32. Nouv Presse Med. 1974. PMID: 4836506 French. No abstract available.
• Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.

  Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR, Nelson SD. Mitchell JR, et al. Ann Intern Med. 1976 Feb;84(2):181-92. doi: 10.7326/0003-4819-84-2-181. Ann Intern Med. 1976. PMID: 766682 Review.